BDNF and Parkinson disease: A recent study has highlighted that pregnenolone, even at a low dose of 6 mg/kg, effectively prevents L-DOPA-induced dyskinesias by decreasing 6-OHDA lesions in the rat model of PD without affecting L-DOPA-induced motor improvements and its ability to modulate striatal BDNF levels [160].